Malchow H, Sewing K F, Albinus M, Horn B, Schomerus H, Dölle W
Dtsch Med Wochenschr. 1978 Jan 27;103(4):149-52. doi: 10.1055/s-0028-1104397.
The effect of 300 mg cimetidine q.i.d. on ulcer healing was studied in a controlled double-blind clinical trial of 71 in-patients with duodenal ulcer. Healing occurred in 48.5% of patients in the cimetidine group after two weeks, and in 20.6% in the placebo group (P less than 0.05). The healing rate was 88% in the cimetidine group at four weeks, 79.4% in the placebo group. Only during the first day was ulcer pain significantly reduced in the cimetidine-treated patients. Neither basal nor pentagastrin-stimulated acid and pepsin secretions were affected by 17-day administration of cimetidine. The drug had to be withdrawn in two patients because of elevated serum-creatinine levels. There was no other untoward effect.
在一项针对71名十二指肠溃疡住院患者的对照双盲临床试验中,研究了每日四次服用300毫克西咪替丁对溃疡愈合的影响。两周后,西咪替丁组48.5%的患者溃疡愈合,安慰剂组为20.6%(P<0.05)。四周时,西咪替丁组的愈合率为88%,安慰剂组为79.4%。仅在第一天,接受西咪替丁治疗的患者溃疡疼痛明显减轻。连续17天服用西咪替丁对基础胃酸和胃蛋白酶分泌以及五肽胃泌素刺激的胃酸和胃蛋白酶分泌均无影响。两名患者因血清肌酐水平升高而停药。未出现其他不良反应。